Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.

British journal of cancer - 20 Aug 2007

Dudek A Z, Bodempudi V, Welsh B W, Jasinski P, Griffin R J, Milbauer L, Hebbel R P

Abstract excerpt

Angiogenesis and post-natal vasculogenesis are two processes involved in the formation of new vessels, and both are essential for tumour growth and metastases. We isolated endothelial cells from human blood mononuclear cells by selective culture. These blood outgrowth cells expressed endothelial cell markers and responded correctly to functional assays. To evaluate the potential of blood outgrowth endothelial...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Endothelial Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Mice, Inbred NOD

Share to Mice, Nude

Share to Mice, SCID

Share to Neoplasm Transplantation

Share to Neovascularization, Pathologic

Source

Open in PubMed Open full text

Identifiers

PMID: 17653078
DOI: 10.1038/sj.bjc.6603883
PMCID: PMC2360342

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systemic inhibition of tumour angiogenesis by endothelial cell-based gene therapy.PMID 17653078Read ↗

Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors.Semantic proximity Read ↗

Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.Semantic proximity Read ↗

Endothelial lineage cell as a vehicle for systemic delivery of cancer gene therapy.Semantic proximity Read ↗

Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapySemantic proximity Read ↗

Progress in antiangiogenic gene therapy of cancerSemantic proximity Read ↗

Are tumours angiogenesis-dependent?Semantic proximity Read ↗

Altered angiogenesis and survival in human tumor‐derived endothelial cellsSemantic proximity Read ↗

Bone marrow derived cells in the tumour microenvironment contain cells with primitive haematopoietic phenotype.Semantic proximity Read ↗

Development of a new method for isolation and long‐term culture of organ‐specific blood vascular and lymphatic endothelial cells of the mouseSemantic proximity Read ↗

<i>In Vivo</i> Targeting of Tumor Endothelial Cells by Systemic Delivery of Lentiviral VectorsSemantic proximity Read ↗

Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug ResistanceSemantic proximity Read ↗

Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.